Annual CFF
$133.54 M
+$31.61 M+31.01%
December 31, 2023
Summary
- As of February 7, 2025, VERA annual cash flow from financing activities is $133.54 million, with the most recent change of +$31.61 million (+31.01%) on December 31, 2023.
- During the last 3 years, VERA annual CFF has risen by +$48.25 million (+56.57%).
- VERA annual CFF is now at all-time high.
Performance
VERA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$739.00 K
-$2.70 M-78.51%
September 30, 2024
Summary
- As of February 7, 2025, VERA quarterly cash flow from financing activities is $739.00 thousand, with the most recent change of -$2.70 million (-78.51%) on September 30, 2024.
- Over the past year, VERA quarterly CFF has dropped by -$24.09 million (-97.02%).
- VERA quarterly CFF is now -99.73% below its all-time high of $276.54 million, reached on March 31, 2024.
Performance
VERA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$305.55 M
+$442.00 K+0.14%
September 30, 2024
Summary
- As of February 7, 2025, VERA TTM cash flow from financing activities is $305.55 million, with the most recent change of +$442.00 thousand (+0.14%) on September 30, 2024.
- Over the past year, VERA TTM CFF has increased by +$172.00 million (+128.80%).
- VERA TTM CFF is now at all-time high.
Performance
VERA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VERA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.0% | -97.0% | +128.8% |
| 3 y3 years | +56.6% | +100.0% | +137.3% |
| 5 y5 years | +10000.0% | -85.1% | +6051.5% |
VERA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.8% | -99.7% | +1439.6% | at high | +467.1% |
| 5 y | 5-year | at high | >+9999.0% | -99.7% | +886.2% | at high | +6051.5% |
| alltime | all time | at high | >+9999.0% | -99.7% | +886.2% | at high | +6051.5% |
Vera Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $739.00 K(-78.5%) | $305.55 M(+0.1%) |
| Jun 2024 | - | $3.44 M(-98.8%) | $305.10 M(+1.0%) |
| Mar 2024 | - | $276.54 M(+1013.8%) | $302.10 M(+126.2%) |
| Dec 2023 | $133.54 M(+31.0%) | $24.83 M(+8259.6%) | $133.54 M(+3.2%) |
| Sep 2023 | - | $297.00 K(-31.3%) | $129.42 M(-0.5%) |
| Jun 2023 | - | $432.00 K(-99.6%) | $130.03 M(+0.3%) |
| Mar 2023 | - | $107.98 M(+421.4%) | $129.65 M(+27.2%) |
| Dec 2022 | $101.93 M | $20.71 M(+2180.7%) | $101.93 M(+18.3%) |
| Sep 2022 | - | $908.00 K(+1791.7%) | $86.14 M(+1.1%) |
| Jun 2022 | - | $48.00 K(-99.9%) | $85.24 M(-36.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $80.27 M(+1531.1%) | $134.18 M(+149.0%) |
| Dec 2021 | $53.88 M(-36.8%) | $4.92 M(>+9900.0%) | $53.88 M(-58.2%) |
| Sep 2021 | - | $0.00(-100.0%) | $128.76 M(+0.1%) |
| Jun 2021 | - | $48.99 M(<-9900.0%) | $128.67 M(+60.2%) |
| Mar 2021 | - | -$28.00 K(-100.0%) | $80.30 M(-5.9%) |
| Dec 2020 | $85.29 M(<-9900.0%) | - | - |
| Dec 2020 | - | $79.80 M(<-9900.0%) | $85.29 M(+1453.8%) |
| Sep 2020 | - | -$94.00 K(-115.3%) | $5.49 M(-1.7%) |
| Jun 2020 | - | $616.00 K(-87.6%) | $5.58 M(+12.4%) |
| Mar 2020 | - | $4.97 M | $4.97 M |
| Dec 2019 | -$137.00 K | - | - |
FAQ
- What is Vera Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Vera Therapeutics?
- What is Vera Therapeutics annual CFF year-on-year change?
- What is Vera Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Vera Therapeutics?
- What is Vera Therapeutics quarterly CFF year-on-year change?
- What is Vera Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Vera Therapeutics?
- What is Vera Therapeutics TTM CFF year-on-year change?
What is Vera Therapeutics annual cash flow from financing activities?
The current annual CFF of VERA is $133.54 M
What is the all time high annual CFF for Vera Therapeutics?
Vera Therapeutics all-time high annual cash flow from financing activities is $133.54 M
What is Vera Therapeutics annual CFF year-on-year change?
Over the past year, VERA annual cash flow from financing activities has changed by +$31.61 M (+31.01%)
What is Vera Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of VERA is $739.00 K
What is the all time high quarterly CFF for Vera Therapeutics?
Vera Therapeutics all-time high quarterly cash flow from financing activities is $276.54 M
What is Vera Therapeutics quarterly CFF year-on-year change?
Over the past year, VERA quarterly cash flow from financing activities has changed by -$24.09 M (-97.02%)
What is Vera Therapeutics TTM cash flow from financing activities?
The current TTM CFF of VERA is $305.55 M
What is the all time high TTM CFF for Vera Therapeutics?
Vera Therapeutics all-time high TTM cash flow from financing activities is $305.55 M
What is Vera Therapeutics TTM CFF year-on-year change?
Over the past year, VERA TTM cash flow from financing activities has changed by +$172.00 M (+128.80%)